Use my Search Websuite to scan PubMed, PMCentral, Journal Hosts and Journal Archives, FullText. Kick-your-searchterm to multiple Engines kick-your-query now !>

A dictionary by aggregated review articles of nephrology, medicine and the life sciences Your one-stop-run pathway from word to the immediate pdf of peer-reviewed on-topic knowledge.

10.1016/j.vaccine.2021.02.048 http://scihub22266oqcxt.onion/10.1016/j.vaccine.2021.02.048 33714656!ä!33714656 Deprecated: Implicit conversion from float 231.6 to int loses precision in C:\Inetpub\vhosts\kidney.de\httpdocs\pget.php on line 534 Deprecated: Implicit conversion from float 231.6 to int loses precision in C:\Inetpub\vhosts\kidney.de\httpdocs\pget.php on line 534       Vaccine 2021 ; 39 (14): 1892-1896 Nephropedia Template TP {{tp|p=33714656|t=2021. Ancillary benefits of seasonal influenza vaccination in middle-income countries |pdf=|usr=}}{{33714656}} gab.com Text Ancillary benefits of seasonal influenza vaccination in middle-income countries JO: Vaccine http://www.kidney.de/pget.php?&tw=1&pmid=33714656 #FOAvip While seasonal influenza vaccines (SIV) remain the best method to prevent influenza-associated illnesses, implementing SIV programs may benefit countries beyond disease reduction, strengthening health systems and national immunization programs, or conversely, introduce new challenges. Few studies have examined perceived impacts of SIV introduction beyond disease reduction on health systems; understanding such impacts will be particularly salient in the context of COVID-19 vaccine introduction. We collected qualitative data from key informants-Partnership for Influenza Vaccine Introduction (PIVI) contacts in six middle-income PIVI vaccine recipient countries-to understand perceptions of ancillary benefits and challenges from SIV implementation. Respondents reported benefits associated with SIV introduction, including improved attitudes to SIV among risk groups (characterized by increased demand) and perceptions that SIV introduction improved relationships with other ministries and collaboration with mass media. Challenges included sustaining investment in SIV programs, as vaccine supply did not always meet coverage goals, and managing SIV campaigns. Twit Text FOAVip Ancillary benefits of seasonal influenza vaccination in middle-income countries ????Vaccine http://www.kidney.de/pget.php?&tw=1&pmid=33714656 #FOAvip Twit Text # Free Paper on # # # # # LINK http://www.kidney.de/pget.php?&tw=1&pmid=33714656 #FOAvip English Wikipedia <ref>{{Cite pmid|33714656}}</ref> Ancillary benefits of seasonal influenza vaccination in middle-income countries #MMPMID33714656 Ebama MS; Chu SY; Azziz-Baumgartner E; Lafond KE; McCarron M; Hadler SC; Porter RM; McKinlay M; Bresee J Vaccine 2021[Apr]; 39 (14): 1892-1896 PMID33714656show ga While seasonal influenza vaccines (SIV) remain the best method to prevent influenza-associated illnesses, implementing SIV programs may benefit countries beyond disease reduction, strengthening health systems and national immunization programs, or conversely, introduce new challenges. Few studies have examined perceived impacts of SIV introduction beyond disease reduction on health systems; understanding such impacts will be particularly salient in the context of COVID-19 vaccine introduction. We collected qualitative data from key informants-Partnership for Influenza Vaccine Introduction (PIVI) contacts in six middle-income PIVI vaccine recipient countries-to understand perceptions of ancillary benefits and challenges from SIV implementation. Respondents reported benefits associated with SIV introduction, including improved attitudes to SIV among risk groups (characterized by increased demand) and perceptions that SIV introduction improved relationships with other ministries and collaboration with mass media. Challenges included sustaining investment in SIV programs, as vaccine supply did not always meet coverage goals, and managing SIV campaigns. |*Developing Countries[MESH] |*Immunization Programs[MESH] |Humans[MESH] |Influenza Vaccines/*administration & dosage[MESH] |Influenza, Human/*prevention & control[MESH]Ancillary benefits of seasonal influenza vaccination in middle-income (epmc).pdf DeepDyve Pubget Overpricing